Lancet HaematologySCIE

文章摘录

• Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study Author: Shadman, Mazyar; Flinn, Ian W.; Levy, Moshe Y.; Porter, Ryan F.; Burke, John M.; Zafar, Syed F.; Misleh, Jamal; Kingsley, Edwin C.; Yimer, Habte A.; Freeman, Benjamin; Rao, Subramanya S.; Chaudhry, Arvind; Tumula, Praveen K.; Gandhi, Mitul D.; Manda, Sudhir; Chen, Dih-Yih; By, Kunthel; Xu, Linlin; Liu, Ye; Crescenzo, Rocco; Idoine, Adam; Zhang, Xiaoping; Cohen, Aileen; Huang, Jane; Sharman, Jeff P. Journal: LANCET HAEMATOLOGY. 2023; Vol. 10, Issue 1, pp. E35-E45. DOI: 10.1016/S2352-3026(22)00320-9
• The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3trial Author: Xuan, Li; Dai, Min; Jiang, Erlie; Wang, Yu; Huang, Fen; Fan, Zhiping; Xu, Na; Nie, Danian; Liang, Xinquan; Chen, Hong; Ye, Jieyu; Shi, Pengcheng; Liu, Hui; Jin, Hua; Lin, Ren; Yan, Chenhua; Zhang, Yu; Sun, Jing; Han, Mingzhe; Liu, Qifa Journal: LANCET HAEMATOLOGY. 2023; Vol. 10, Issue 3, pp. E178-E190. DOI: 10.1016/S2352-3026(22)00375-1
• Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial Author: Yuankai Shi, Hang Su, Yongping Song, Wenqi Jiang, Xiuhua Sun, Wenbin Qian, Wei Zhang, Yuhuan Gao, Zhengming Jin, Jianfeng Zhou, Chuan Jin, Liqun Zou, Lugui Qiu, Wei Li, Jianmin Yang, Ming Hou, Shan Zeng, Qingyuan Zhang, Jianda Hu, Hui Zhou, Yan Xiong, Peng Liu Journal: Lancet Haematology, 2019, Vol.6, e12-e19, DOI:10.1016/s2352-3026(18)30192-3
• Immunoglobulin therapy and passive transfer of anti-HBc: too often forgotten Author: Edwin Pun Hui Journal: Lancet Haematology, 2018, Vol.5, e437-e438, DOI:10.1016/s2352-3026(18)30158-3
• Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial Author: Fei-Er Feng, Ru Feng, Min Wang, Jia-Min Zhang, Hao Jiang, Qian Jiang, Jin Lu, Hui Liu, Jun Peng, Ming Hou, Jian-Liang Shen, Jing-Wen Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang Journal: Lancet Haematology, 2017, Vol.4, e487-e496, DOI:10.1016/s2352-3026(17)30170-9
• Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. Author: Tang L, Wu YY, Lip GY, Yin P, Hu Y. Journal: Lancet Haematol. 2016 Jan;3(1):e30-44. doi: 10.1016/S2352-3026(15)00228-8. Epub 2015 Dec 4.
• Safety and current status of blood transfusion in China: an update. Author: Yu X, Chen W, Liu Z, Huang Y. Journal: Lancet Haematol. 2016 Feb;3(2):e60-2. doi: 10.1016/S2352-3026(16)00010-7. No abstract available.
• Safety and current status of blood transfusion in China: an update Author: Xuerong Yu, Weiyun Chen, Zhong Liu, Yuguang Huang Journal: Lancet Haematology, 2016, Vol.3, e60-e62, DOI:10.1016/s2352-3026(16)00010-7